Logo image of HAO

HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock Fundamental Analysis

NASDAQ:HAO - Nasdaq - KYG4290F1182 - Common Stock - Currency: USD

1.2  +0.05 (+4.35%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HAO. HAO was compared to 98 industry peers in the Media industry. While HAO has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, HAO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year HAO was profitable.
HAO had a negative operating cash flow in the past year.
HAO Yearly Net Income VS EBIT VS OCF VS FCFHAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

HAO has a Return On Assets of 13.23%. This is amongst the best in the industry. HAO outperforms 96.94% of its industry peers.
HAO has a better Return On Equity (18.20%) than 87.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.84%, HAO belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROIC 15.84%
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAO Yearly ROA, ROE, ROICHAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

HAO has a better Profit Margin (2.85%) than 67.35% of its industry peers.
HAO's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 3.52%, HAO perfoms like the industry average, outperforming 48.98% of the companies in the same industry.
HAO's Operating Margin has improved in the last couple of years.
HAO has a worse Gross Margin (5.49%) than 86.73% of its industry peers.
HAO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
HAO Yearly Profit, Operating, Gross MarginsHAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HAO is creating value.
Compared to 1 year ago, HAO has more shares outstanding
Compared to 1 year ago, HAO has an improved debt to assets ratio.
HAO Yearly Shares OutstandingHAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
HAO Yearly Total Debt VS Total AssetsHAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

HAO has an Altman-Z score of 6.60. This indicates that HAO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.60, HAO belongs to the best of the industry, outperforming 88.78% of the companies in the same industry.
HAO has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
HAO has a Debt to Equity ratio of 0.10. This is in the better half of the industry: HAO outperforms 74.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 6.6
ROIC/WACC2.22
WACC7.15%
HAO Yearly LT Debt VS Equity VS FCFHAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

HAO has a Current Ratio of 3.98. This indicates that HAO is financially healthy and has no problem in meeting its short term obligations.
HAO's Current ratio of 3.98 is amongst the best of the industry. HAO outperforms 93.88% of its industry peers.
A Quick Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
HAO has a Quick ratio of 3.98. This is amongst the best in the industry. HAO outperforms 93.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
HAO Yearly Current Assets VS Current LiabilitesHAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.32% over the past year.
Measured over the past years, HAO shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.60% on average per year.
Looking at the last year, HAO shows a very strong growth in Revenue. The Revenue has grown by 92.62%.
Measured over the past years, HAO shows a very strong growth in Revenue. The Revenue has been growing by 55.73% on average per year.
EPS 1Y (TTM)68.32%
EPS 3Y61.6%
EPS 5YN/A
EPS Q2Q%38.82%
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HAO Yearly Revenue VS EstimatesHAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.14, the valuation of HAO can be described as rather expensive.
69.39% of the companies in the same industry are more expensive than HAO, based on the Price/Earnings ratio.
HAO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.41.
Industry RankSector Rank
PE 17.14
Fwd PE N/A
HAO Price Earnings VS Forward Price EarningsHAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.43
HAO Per share dataHAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HAO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAOXI HEALTH TECHNOLOGY LTD

NASDAQ:HAO (8/12/2025, 11:48:43 AM)

1.2

+0.05 (+4.35%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.78%
Inst Owner Change0%
Ins Owners21.79%
Ins Owner ChangeN/A
Market Cap3.38M
Analysts0
Price TargetN/A
Short Float %2.77%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.14
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA -1.43
EPS(TTM)0.07
EY5.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS25.54
BVpS4
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROCE 21.78%
ROIC 15.84%
ROICexc 35.58%
ROICexgc 35.58%
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
FCFM N/A
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
F-Score3
Asset Turnover4.64
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.45
Cap/Depr 522.64%
Cap/Sales 0.08%
Interest Coverage 67.98
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z 6.6
F-Score3
WACC7.15%
ROIC/WACC2.22
Cap/Depr(3y)486.59%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.32%
EPS 3Y61.6%
EPS 5YN/A
EPS Q2Q%38.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.42%
EBIT growth 3Y73.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.28%
OCF growth 3YN/A
OCF growth 5YN/A